Optovue Solix OCT-Angiography by Visionix: Practice Building and Patient Care for Diabetes with Dr. Julie Rodman


Site Administrator & Tech Lead
Staff member
Feb 24, 2001
University of Michigan Medical School
Lake Oswego

Are you interested in adding OCT-Angiography (OCT-A) to your practice? Do you want to provide better care for your patients with diabetes?

This webinar highlights the Optovue Solix by Visionix -- learn how OCT-A can help you build your practice and provide a greater level of care.

Attendees of the webinar will explore:
  • How OCT & OCT-A provide different but complementary information Exclusive
  • AngioAnalytics: First OCT-A 3D technology, non-invasive diagnostics for early detection, FDA cleared metrics, and better R&R
  • How to find and monitor disease with OCT-A
  • Real cases where OCT-A made a difference in care
  • And MORE!

About the Speaker

Dr. Julie Rodman is the Chief of the Broward Eye Care Institute in Fort Lauderdale, FL and a Professor of Optometry at Nova Southeastern University.
Her research interests include OCT/OCT-A and Vitreoretinal Disease. Dr. Rodman has authored over thirty publications with an emphasis on retinal disease.

She recently published "Optical Coherence Tomography Atlas: A Case Study Approach," the first reference book on this topic written by an optometrist.

Dr. Rodman is a member of the AOA, AAO, FOA, and ORS. She has been the recipient of numerous teaching awards and was recognized as a Primary Care Optometry News "Top 300" Optometrists and "Newsweek Best Optometrists of 2021."

About Visionix

Visionix is the global manufacturer and exclusive sales, service, and training provider for Optovue OCT, Visionix screening and refraction systems, as well as Briot and Weco lens finishing equipment in North America. We are a pioneer in integrating core refractive, screening, and imaging technologies to address the ever-changing needs of eye care professionals.

Today, we are proud to offer high-speed OCT and OCT-A technology designed to facilitate the diagnosis and management of a range of ocular diseases. Our goal is to improve access to a complete suite of advanced visual health solutions that transform the patient experience.

With over 100 years of innovation, an expanded product line, as well as a new level of support, clinical education, and practice integration, we are well-positioned to help you unlock your potential.
Thanks again to Dr. Rodman for this talk -- feel free to ask follow-up questions in this thread!